Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Archives of Internal Medicine|June 12, 1995
Outcome analysis of 34 pregnancies in women with essential thrombocythemiaA H Beressi, A Tefferi, M N Silverstein, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indicationsA Tefferi, M N Silverstein, R M Petitt, et al.
Cancer Genetics and Cytogenetics|November 1, 1985
Deletions of chromosome 13 in malignant hematologic disordersD D Johnson, G W Dewald, R V Pierre, et al.
American Journal of Surgery|November 1, 1982
Adrenal surgery: trends during the seventiesB Hamberger, C F Russell, J A van Heerden, et al.
Cancer Treatment Reports|January 1, 1980
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomasM J O'Connell, C B Begg, M N Silverstein, et al.
Cancer Treatment Reports|September 1, 1987
Contribution of prednisone to the effectiveness of hexamethylmelamine in multiple myelomaM M Oken, R E Lenhard, A A Tsiatis, et al.
Cancer|July 1, 1980
Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma: a progress reportE Z Ezdinli, W G Costello, M N Silverstein, et al.
The New England Journal of Medicine|May 19, 1988
Anagrelide: a new drug for treating thrombocytosisM N Silverstein, R M Petitt, L A Solberg, et al.
American Journal of Hematology|October 1, 1994
Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989B J Anía, V J Suman, J L Sobell, et al.
Cancer|April 1, 1984
High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myelomaR E Lenhard, M M Oken, J M Barnes, et al.
Pageof 6